0001209191-21-049380.txt : 20210803
0001209191-21-049380.hdr.sgml : 20210803
20210803165947
ACCESSION NUMBER: 0001209191-21-049380
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210803
FILED AS OF DATE: 20210803
DATE AS OF CHANGE: 20210803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lamb Lawrence
CENTRAL INDEX KEY: 0001830059
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39692
FILM NUMBER: 211140740
MAIL ADDRESS:
STREET 1: C/O IN8BIO, INC.
STREET 2: 79 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IN8BIO, INC.
CENTRAL INDEX KEY: 0001740279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825462585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 MADISON AVENUE, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: (646) 600-6438
MAIL ADDRESS:
STREET 1: 79 MADISON AVENUE, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Incysus Therapeutics, Inc.
DATE OF NAME CHANGE: 20180510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-03
0
0001740279
IN8BIO, INC.
INAB
0001830059
Lamb Lawrence
C/O IN8BIO, INC.
79 MADISON AVENUE
NEW YORK
NY
10016
0
1
0
0
EVP and CSO
Employee Stock Option (right to buy)
1.0685
2021-08-03
4
A
0
22082
0.00
A
2031-08-03
Common Stock
22082
83582
D
All of the shares subject to the option shall vest on the date six months after August 3, 2021, subject to the Reporting Person continuing to provide service through such date.
/s/ Jason Minio, Attorney-in-Fact
2021-08-03